Parkin suppresses wild-type α-synuclein-induced toxicity in SHSY-5Y cells

Biochemical and Biophysical Research Communications

Volumn 309, Issue 3, 2003, Pages 679-684

  Oluwatosin Chigbu, Yemisi ^a   Robbins, Alan ^a   Scott, Clay W ^a   Arriza, Jeffrey L ^a   Reid, John D ^a   Zysk, John R ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Adenoviral gene delivery; Dopaminergic cell line; Parkin; Parkinson's disease; Synucleopathies; Synuclein

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; PARKIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; VIRUS INFECTION; WESTERN BLOTTING; WILD TYPE;

EID: 0042330407     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.059     Document Type: Article

References (29)

1. Jenner P., Olanow C.W. Understanding cell death in Parkinsons-disease. Ann. Neurol. 44:1998;S72-S84.
2. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature. 392:1998;605-608.
3. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25:2000;302-305.
4. Imai Y., Soda M., Takahashi R. Parkin supresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275:2000;35661-35664.
5. Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., Dawson T.M. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA. 97:2000;13354-13359.
6. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
7. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Reiss O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
8. Lücking C.B., Brice A. Alpha-synuclein and Parkinson's disease. Cell. Mol. Life Sci. 57:2000;1894-1908.
9. Goldberg M.S., Lansbury P.T. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol. 2:2000;E115-E119.
10. Giasson B.I., Duda J.E., Murray I.V.J., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M.-Y. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989.
11. Lee H.-J., Shin S.Y., Choi C., Lee Y.H., Lee S.-J. Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol.Chem. 277:2002;5411-5417.
12. Hyun D.-H., Lee M.H., Hattori N., Kubo S.-I., Mizuno Y., Halliwell B., Jenner P. Effect of wild-type or mutant parkin on oxidative damage, antioxidant defenses, and the proteosome. J. Biol. Chem. 277:2002;28572-28577.
13. Choi P., Golts N., Snyder H., Chong M., Petrucelli L., Hardy J., Sparkman D., Cochran E., Lee J.M., Wolozin B. Co-association of parkin and α-synuclein. Mol. Neurosci. 12:2001;2839-2843.
14. Schlossmacher M.G., Frosch M.P., Gai W.P., Medina M., Sharma N., Forno L., Ochiishi T., Shimura H., Sharon R., Hattori N., Langston J.W., Mizuno Y., Hyman B., Selkoe D., Kosik K.S. Parkin localizes to the Lewy bodies of Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 160:2002;1655-1667.
15. Petrucelli L., O'Farell C., Lockhart P.J., Baptista M., Kehoe K., Vink L., Choi P., Wolozin B., Farrer M., Hardy J., Cookson M.R. Parkin protects against the toxicity associated with mutant α-synuclein: proteosome dysfunction selectively affects catecholaminergic neurons. Neuron. 36:2002;1007-1019.
16. Xu J., Kao S.-Y., Lee F.J.S., Song W., Jin L.-W., Yankner B.A. Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8:2002;600-606.
17. Chesselet M.-F. Dopamine and Parkinson's disease: is the killer in the house? Mol. Psychol. 8:2003;369-370.
18. Zhou W., Schaack J., Zawada W.M., Freed C.R. Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res. 926:2002;42-50.
19. Beal M.F. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23:2000;298-304.
20. Nicklas W.J., Vyas I., Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36:1985;2503-2508.
21. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
22. Crouch S., Kozlowski R., Slater K., Fletcher J. The use of ATP bioluminescence as a measure of proliferation and cytotoxicity. J. Immunol. Methods. 160:1993;81-88.
23. Slater K. Cytotoxicity tests for high throughput drug discovery. Curr. Opin. Biotechnol. 12:2001;70-74.
24. Obrien J., Wilson I., Orton T., Pognan F. Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267:2000;5421-5426.
25. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a parkin substrate. Cell. 105:2001;891-902.
26. Yang Y., Nishimura I., Imai Y., Takahashi R., Lu B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron. 37:2003;911-924.
27. Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K.S., Selkoe D.J. Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science. 293:2001;263-268.
28. Chung K.K.K., Dawson V.L., Dawson T.M. The role of the ubiquitin-proteosomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurol. Sci. 24:2001;S7-S14.
29. Betarbet R., Sherer T.B., Greenamyre J.T. Animal models of Parkinson's disease. BioEssays. 24:2002;308-318.